Mastodon Scientific Frontline: China-wide study will boost understanding of fatal surgical complication

Tuesday, December 21, 2021

China-wide study will boost understanding of fatal surgical complication

Older patients in hospitals across China took part in a major multi-center open-label randomized clinical trial that showed there was no difference in post-operative delirium in older people with a hip fracture, if they had a general anesthesia, or a regional anesthesia.

Post-operative delirium is a common, serious, neurological, complication where people have a sudden change in their brain functions after an operation. It is more common in older people, and leads to increased death, dementia, post-traumatic stress disorder, a longer length of hospital stay, extra nursing requirements and increased healthcare costs.

People with a hip fracture require an operation to fix the fracture which requires anesthesia - classified as general anesthesia, or regional anesthesia. A general anesthetic technique involves inducing sleep or loss of consciousness through inhaled or intravenous anesthetics. Regional anesthesia involves injecting local anesthetic inside the spine or around the nerves to prevent pain in the leg with the hip fracture.

It was commonly thought that one of the causes of delirium is a general anesthesia. Led by the University of Birmingham and Wenzhou Medical University Second Affiliated Hospital, this randomized trial was the first of its kind in China. 950 older adult took part, from hospitals in Wenzhou, Wuhan, Lishui, Ningbo, Nanchang, and Taizhou.

The trial was set up to provide clinical evidence with a robust methodology, to help medical professionals select appropriate anesthesia for older patients to try and reduce the development of delirium.

Researchers in Birmingham and WenZhou today published the findings in JAMA. After the hip fracture surgery, delirium occurred in 6.2% of the group who had general anesthesia, and 5.1% in those who had a regional anesthesia. The difference between the two groups could be explained by chance.

The Chief Investigator of RAGA trial, Professor Fang Gao, from the University of Birmingham, NIHR Senior Investigator, commented: “There is a high incidence of delirium after surgery in hip fracture patients, but we had no robust evidence demonstrating the effectiveness of the two most commonly used anesthetic techniques causing delirium - creating an urgent need to investigate delirium prevention.

“The causes of delirium remain poorly understood, but our trial highlights that factors such as general anesthetic agents, that we thought may be associated with delirium, are in fact unlikely to cause delirium.”

“Our trial has also provided clinical evidence on the safety of RA and GA in older patients for hip fracture surgery, helping anesthetists in selecting appropriate anesthesia for these patients - particularly those at high risk of POD.”

The older population has grown quickly over the last 20 years in most parts of the world and the number of older people undergoing surgical procedures has increased. Hip fractures are a global health problem, with over 1.6 million patients suffering such injuries worldwide every year. Some 680 000 of these injuries occur among the 70 million elderly people in China and it is predicted that 50% of total global hip fractures will occur in Asia by 2050.

Dr Thomas Jackson, Associate Professor in Geriatric Medicine and Board member of the European Delirium Association says; “Delirium is first and foremost a destressing condition for the suffer and their care givers, and to date we have no treatments we know to shorten or stop delirium when it develops.

“This trial is an important step forward in our understanding of how people develop delirium after an operation. By demonstrating that a general anesthetic is not a probable cause of delirium will allow researchers to further study other areas, such as the bodies inflammatory response to the surgery itself, and how this carries over into the brain.”

Source/Credit: University of Birmingham

med122121_01

Featured Article

Experimental COVID-19 Vaccine Offers Long-Term Protection Against Severe Disease

A study involving rhesus macaques at the California National Primate Research Center shows that COVID-19 vaccines given to infant animals pr...

Top Viewed Articles